IGF1 and neoplasm: In addition to the PI3K / AKT / mTOR integrated pathway, fasting can also inhibit the activity of the RAS/MAP nutrient signaling pathway by reducing IGF-1 levels, inhibiting the activity of transcription factors in tumor cells, and subsequently expressing genes involved in proliferation and cell growth [77, 78].